biotuesdays.com’s feature piece on Labopharm “in the news”

At approximately 8:00 AM ET today, this week’s feature article was posted to biotuesdays.com.  Written by Len Zehr, the piece provided Labopharm’s (TSX:DDS; NASDAQ:DDSS) CEO, James Howard-Tripp, with an opportunity to map out where his company is heading in 2010 and beyond.   In the first five hours alone, the post attracted more than 654 unique visitors (and over 718 page views).

The article also seems to have positively impacted Labopharm’s stock trading activity.  For coverage of that, please see this story from TheStreet.com.